- Home
- AAME vs ALGS Comparison
AAME vs ALGS Comparison
Compare AAME & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAME | ALGS |
|---|---|---|
| Founded | 1968 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 34.6M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AAME | ALGS |
|---|---|---|
| Price | $1.34 | $6.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 66.1K | ★ 124.6K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $188,227,000.00 | $2,186,000.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | $6.09 | ★ N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $1.25 | $3.98 |
| 52 Week High | $3.46 | $13.69 |
Technical Indicators
Market Signals| Indicator | AAME | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 48.90 |
| Support Level | $1.25 | $4.80 |
| Resistance Level | $1.69 | $6.91 |
| Average True Range (ATR) | 0.11 | 0.58 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 34.30 | 28.91 |
Price Performance
Historical ComparisonAbout AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.